Larry Biegelsen
Stock Analyst at Wells Fargo
(3.88)
# 662
Out of 5,090 analysts
348
Total ratings
56.45%
Success rate
7.37%
Average return
Main Sectors:
Stocks Rated by Larry Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Maintains: Overweight | $100 → $114 | $102.23 | +11.51% | 19 | Nov 19, 2025 | |
| SYK Stryker | Maintains: Overweight | $452 → $456 | $365.83 | +24.65% | 17 | Nov 14, 2025 | |
| BLCO Bausch + Lomb | Maintains: Equal-Weight | $16 → $17 | $17.15 | -0.85% | 9 | Nov 14, 2025 | |
| MMSI Merit Medical Systems | Maintains: Overweight | $103 → $95 | $84.30 | +12.69% | 12 | Nov 14, 2025 | |
| COO The Cooper Companies | Downgrades: Equal-Weight | $72 | $81.93 | -12.12% | 19 | Nov 13, 2025 | |
| TFX Teleflex | Maintains: Equal-Weight | $131 → $114 | $120.14 | -5.11% | 7 | Nov 7, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Equal-Weight | $13 → $14 | $21.09 | -33.62% | 11 | Nov 7, 2025 | |
| RXST RxSight | Maintains: Equal-Weight | $9 → $10 | $12.96 | -22.84% | 15 | Nov 6, 2025 | |
| INSP Inspire Medical Systems | Upgrades: Overweight | $101 → $90 | $138.35 | -34.95% | 14 | Nov 4, 2025 | |
| DXCM DexCom | Maintains: Overweight | $98 → $93 | $66.48 | +39.89% | 10 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $120 → $122 | $109.81 | +11.10% | 17 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $89 → $87 | $84.17 | +3.36% | 5 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $124 → $125 | $98.45 | +26.97% | 15 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $599 → $600 | $571.61 | +4.97% | 21 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $170 → $212 | $201.91 | +5.00% | 14 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $0.68 → $0.85 | $1.08 | -21.30% | 6 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $84 → $88 | $87.63 | +0.42% | 17 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Equal-Weight | $93 | $81.40 | +14.25% | 9 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $3 | $2.05 | +46.70% | 7 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $24 | $18.80 | +27.69% | 17 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $315 → $290 | $301.23 | -3.73% | 19 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $40 → $15 | $12.10 | +19.88% | 18 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $27 | $24.47 | +10.34% | 2 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $113 → $98 | $94.39 | +3.82% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $17 | $16.73 | +1.64% | 1 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $40 → $49 | $13.67 | +258.45% | 2 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $136 | $125.76 | +8.14% | 21 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $70 | $90.36 | -22.53% | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $270 | $195.60 | +38.04% | 5 | Apr 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $63.94 | - | 2 | Nov 2, 2017 |
Medtronic
Nov 19, 2025
Maintains: Overweight
Price Target: $100 → $114
Current: $102.23
Upside: +11.51%
Stryker
Nov 14, 2025
Maintains: Overweight
Price Target: $452 → $456
Current: $365.83
Upside: +24.65%
Bausch + Lomb
Nov 14, 2025
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $17.15
Upside: -0.85%
Merit Medical Systems
Nov 14, 2025
Maintains: Overweight
Price Target: $103 → $95
Current: $84.30
Upside: +12.69%
The Cooper Companies
Nov 13, 2025
Downgrades: Equal-Weight
Price Target: $72
Current: $81.93
Upside: -12.12%
Teleflex
Nov 7, 2025
Maintains: Equal-Weight
Price Target: $131 → $114
Current: $120.14
Upside: -5.11%
Tandem Diabetes Care
Nov 7, 2025
Maintains: Equal-Weight
Price Target: $13 → $14
Current: $21.09
Upside: -33.62%
RxSight
Nov 6, 2025
Maintains: Equal-Weight
Price Target: $9 → $10
Current: $12.96
Upside: -22.84%
Inspire Medical Systems
Nov 4, 2025
Upgrades: Overweight
Price Target: $101 → $90
Current: $138.35
Upside: -34.95%
DexCom
Oct 31, 2025
Maintains: Overweight
Price Target: $98 → $93
Current: $66.48
Upside: +39.89%
Oct 30, 2025
Maintains: Overweight
Price Target: $120 → $122
Current: $109.81
Upside: +11.10%
Oct 30, 2025
Maintains: Overweight
Price Target: $89 → $87
Current: $84.17
Upside: +3.36%
Oct 23, 2025
Maintains: Overweight
Price Target: $124 → $125
Current: $98.45
Upside: +26.97%
Oct 22, 2025
Maintains: Overweight
Price Target: $599 → $600
Current: $571.61
Upside: +4.97%
Oct 3, 2025
Upgrades: Overweight
Price Target: $170 → $212
Current: $201.91
Upside: +5.00%
Aug 15, 2025
Maintains: Equal-Weight
Price Target: $0.68 → $0.85
Current: $1.08
Upside: -21.30%
Aug 7, 2025
Maintains: Overweight
Price Target: $84 → $88
Current: $87.63
Upside: +0.42%
Aug 6, 2025
Reinstates: Equal-Weight
Price Target: $93
Current: $81.40
Upside: +14.25%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $6 → $3
Current: $2.05
Upside: +46.70%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $33 → $24
Current: $18.80
Upside: +27.69%
Jul 30, 2025
Maintains: Overweight
Price Target: $315 → $290
Current: $301.23
Upside: -3.73%
Jul 25, 2025
Downgrades: Equal-Weight
Price Target: $40 → $15
Current: $12.10
Upside: +19.88%
Jul 17, 2025
Maintains: Overweight
Price Target: $28 → $27
Current: $24.47
Upside: +10.34%
May 6, 2025
Maintains: Equal-Weight
Price Target: $113 → $98
Current: $94.39
Upside: +3.82%
Jan 30, 2025
Maintains: Overweight
Price Target: $13 → $17
Current: $16.73
Upside: +1.64%
Dec 5, 2023
Upgrades: Overweight
Price Target: $40 → $49
Current: $13.67
Upside: +258.45%
Apr 5, 2023
Maintains: Overweight
Price Target: $140 → $136
Current: $125.76
Upside: +8.14%
May 11, 2022
Maintains: Overweight
Price Target: $80 → $70
Current: $90.36
Upside: -22.53%
Apr 8, 2020
Maintains: Overweight
Price Target: $279 → $270
Current: $195.60
Upside: +38.04%
Nov 2, 2017
Upgrades: Outperform
Price Target: n/a
Current: $63.94
Upside: -